Pharma IQ Members

Articles

Pharma IQ is devoted to keeping industry professionals abreast of the latest and most topical pharma news. Our pharmaceutical and biotechnology articles provide pharma professionals with comprehensive access up-to-date pharma news and information. Our pharma and biotech articles provide relevant, timely and actionable industry insight for pharma professionals. 

627 article results
of 63
July 18, 2017 by Elizabeth Mixson
hands
Since early 2014, more than 30 states in the US have introduced so-called "Right to Try" bills in the hopes of allowing terminally ill patients to access experimental and potentially life-saving treatments. Download the PDF to glance at the Right To Try movement in the US.
Tags:
July 14, 2017 by Pharma IQ
AI thumb
Artificial intelligence could herald a new era for drug development but caution remains about how revolutionary its impact will actually be
Tags:
July 14, 2017 by Chanice Henry
Chan
The US FDA’s recommended approval of Novartis’ CAR-T cell therapy pushes the product closer to being the first treatment of its kind available on the market.
Tags:
July 11, 2017 by Pharma IQ
Pharma IQ
Despite some in the market choosing to shut down certain departments, many in the pharma industry are embarking on expansions. Ireland is expected to see a lot of growth
Tags: pharma | medicines | cure
June 30, 2017 by Pharma IQ
Pharma IQ
At the recent CRISPR summit conference Pharma IQ spoke to Ben Borgo of Agilent Technologies about the future of the gene editing technique.
Tags:
June 27, 2017 by Pharma IQ
zika
Last summer, the Zika virus outbreak triggered a worldwide health alert. Today, pathogen is a discovery priority as there is still no treatment in existence to combat the disease
Tags:
June 20, 2017 by Pharma IQ News
Pharma IQ News
The Reputation Institute has revealed the top 10 most reputable pharma companies as voted by the general public. In a surprising result, AstraZeneca and GSK both failed to make the top 10.
Tags:
June 20, 2017 by Chanice Henry
Chan
Amid pressure to limit discovery losses and be more ethically responsible, the pharma industry is slowly bowing to the growing weight of evidence to find alternatives to testing on animals.
Tags:
June 13, 2017 by Chanice Henry
Chan
Astrazeneca and its biologics arm, Medimmune, advance in the R&D race as three new oncology drug candidates see promising developments
Tags:
Georger
New research from The George Institute for Global Health discovers that despite being prescribed more often, the drug pregabalin was no better than a placebo
Tags:
627 article results
of 63